Preischemic Administration of Sevoflurane Does not Exert Dose-dependent Effects on the Outcome of Severe Forebrain Ischemia in Rats
| Autor: | Kaoru Kanazawa, Ikuko Nasu, Yoshihide Miura |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Male
Methyl Ethers Minimum alveolar concentration Ischemia Sevoflurane Brain Ischemia Fentanyl Rats Sprague-Dawley Brain ischemia Prosencephalon Animals Medicine Dose-Response Relationship Drug business.industry medicine.disease Rats Disease Models Animal Anesthesiology and Pain Medicine medicine.anatomical_structure nervous system Isoflurane Cerebral cortex Anesthesia Anesthetics Inhalation Surgery Neurology (clinical) Halothane business medicine.drug |
| Zdroj: | Journal of Neurosurgical Anesthesiology. 27:216-221 |
| ISSN: | 0898-4921 |
| DOI: | 10.1097/ana.0000000000000141 |
| Popis: | We previously showed that preischemic administration of high-dose isoflurane worsened the outcome from severe forebrain ischemia in rats. Conversely, high doses of sevoflurane have been reported to improve the outcome from forebrain ischemia when the insult is moderate. To clarify the dose-dependent effects of sevoflurane on severe forebrain ischemia, we performed an outcome study using an identical protocol to that in our previous study with isoflurane. Fasting male Sprague-Dawley rats underwent surgical preparation for forebrain ischemia under halothane anesthesia. Anesthesia was changed to fentanyl/nitrous oxide to eliminate the halothane, after which 30 minutes of 0.5, 1.0, 1.5, 2.0, or 2.5 minimum alveolar concentration sevoflurane was administered. Ten minutes of ischemia was induced by bilateral carotid occlusion plus systemic hypotension, in which cessation of electroencephalographic activity was confirmed. Sevoflurane was discontinued and anesthesia continued with fentanyl/nitrous oxide for an additional 100 minutes. Outcome evaluation at 5 days postischemia included seizure incidence, mortality rate, neuromotor score, and histologic injuries to the cerebral cortex and hippocampal CA1 and CA3. Different doses of sevoflurane did not statistically affect seizure incidence (10.0% to 18.2%), mortality rate (20.0% to 46.7%), cortical damage (mild to moderate degree), or hippocampal CA1 damage (93.7% to 96.7% neuronal necrosis) or CA3 damage (36.3% to 41.7%). Dose-dependent effects of sevoflurane were not observed for any of the outcome variables assessed in this rat model of severe forebrain ischemia. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|